Details of the Drug
General Information of Drug (ID: DMO4FSH)
Drug Name |
2,4-Dichloro-N-(4-phenyl-thiazol-2-yl)-benzamide
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
CHEMBL61381; 2,4-Dichloro-N-(4-phenyl-1,3-thiazol-2-yl)benzamide; 260790-88-3; (Z)-2,4-dichloro-N-(4-phenylthiazol-2(3H)-ylidene)benzamide; 5307-12-0; AC1LCD3F; CBMicro_016815; Oprea1_161519; 2,4-Dichloro-N-(4-phenyl-thiazol-2-yl)-benzamide; ARONIS019647; KS-00004BJV; DTXSID00344799; MolPort-001-620-431; MWSDOEQEOIKHRL-UHFFFAOYSA-N; MolPort-003-009-221; ZINC4696587; CCG-5657; STK048438; BDBM50101786; AKOS000486711; AKOS024573981; MCULE-1720813827; ST036566; BIM-0016665.P001; N-(4-Phenyl-2-thiazolyl)-2,4-dichlorobenzamide
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 349.2 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 5 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||